Are you Dr. Lee?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 19 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Blvd
Cookeville, TN 38501Phone+1 931-528-2541
Summary
- Dr. Choon-Kee Lee, MD is an oncologist in Cookeville, Tennessee. He is currently licensed to practice medicine in Tennessee, Wisconsin, and Georgia. He is affiliated with Cookeville Regional Medical Center and Erlanger Medical Center.
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1989 - 1990
- Chonnam University Medical SchoolClass of 1981
Certifications & Licensure
- CO State Medical License 2006 - 2025
- TN State Medical License 2020 - 2025
- WI State Medical License 2024 - 2025
- GA State Medical License 2019 - 2023
- WY State Medical License 2012 - 2014
- MI State Medical License 2004 - 2012
- AR State Medical License 2001 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Start of enrollment: 2003 Dec 01
Publications & Presentations
PubMed
- 42 citationsChronic graft versus host disease burden and late transplant complications are lower following adult double cord blood versus matched unrelated donor peripheral blood ...Jonathan A. Gutman, Ross K, Clayton A. Smith, H Myint, Lee Ck
Bone Marrow Transplantation. 2016-07-11 - 10 citationsClonality of neutrophilia associated with plasma cell neoplasms: report of a SETBP1 mutation and analysis of a single institution series.Brett M. Stevens, Julia E. Maxson, Jeffrey W. Tyner, Clayton A. Smith, Jonathan A. Gutman
Leukemia & Lymphoma. 2016-04-02 - 39 citationsTherapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancerShuiliang Wang, Jingcao Huang, Hui Lyu, Bo Cai, Xiaoping Yang
Breast Cancer Research. 2013-10-29